SureTrader
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

INO RSS Feed
Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: Ubertino
Search This Board: 
Last Post: 2/15/2018 6:06:49 PM - Followers: 407 - Board type: Free - Posts Today: 0

Logo: Inovio

www.inovio.com/

http://finance.yahoo.com/q/ks?s=INO

http://finance.aol.com/company/inovio-biomedical-corporation/ino/ase/institutional-ownership

F
ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM


Float: 97.65 M

Shares Outstanding: 127.26 M


Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
 
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis
http://finance.yahoo.com/news/inovio-pharmaceuticals-acquires-early-stage-080000624.html?.tsrc=applewf

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
http://finance.yahoo.com/news/inovio-pharmaceuticals-announces-1-4-080000629.html
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.


Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



 
 



 

SureTrader
INO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#4698  Sticky Note Please stay on topic. The only topic to IH Dan (Retired) 08/02/13 01:15:33 PM
#14197   The immune boosting effect from IL-12 is probably avav1001 02/15/18 06:06:49 PM
#14196   INO could go up big or could go WWIII 02/15/18 01:45:57 PM
#14195   It's only populated in a thin strip just Ubertino 02/10/18 11:34:03 AM
#14194   I love Canada. Spent much time camping up Xrouter 02/10/18 11:25:16 AM
#14193   I love Trump almost as much as Inovio. Ubertino 02/10/18 09:30:34 AM
#14192   Hair doesn't make the man, talk your idol kpisme 02/09/18 05:35:34 PM
#14191   At least Inovio doesn't need a decent haircut! Ubertino 02/09/18 02:23:11 PM
#14190   Why not everybody else so far to the kpisme 02/09/18 01:31:28 PM
#14189   I blame Trump - too much good fake news! Ubertino 02/09/18 12:46:03 PM
#14188   Hitting new 5yr lows again. arvitar 02/09/18 10:49:30 AM
#14187   What a piece of trash! Almost lowest price radly 02/08/18 06:02:40 PM
#14186   Stanford Cancer Vaccine WWIII 02/07/18 07:51:45 PM
#14185   Yeah an its an easy double up now! $$$! harry crumb 02/07/18 09:01:32 AM
#14184   Now hitting new 5yr lows. arvitar 02/06/18 09:34:41 AM
#14183   Can we be done with the down trend! billmick11 02/05/18 04:14:30 PM
#14182   Yes, they need significant news and lots of JTHawk 02/02/18 06:58:15 PM
#14181   Just as I thought, right back in the sewer radly 01/31/18 06:10:31 PM
#14180   Jump in INO stock would come if any avav1001 01/30/18 04:49:46 PM
#14179   Isnt INOVIO a stock within a heartbeat could slopak 01/28/18 06:53:40 AM
#14178   Interesting article with a significant finding. So growing avav1001 01/27/18 08:16:07 PM
#14177   Yes, perhaps the algorithm is to give the avav1001 01/24/18 07:53:27 PM
#14176   There's still tomorrow radly 01/24/18 06:44:42 PM
#14175   Well at least we didn’t give back all DrStockonomics 01/24/18 04:01:14 PM
#14174   Worth plenty! Ubertino 01/24/18 03:33:05 PM
#14173   How predictable this is radly 01/24/18 10:35:20 AM
#14172   I smell a buyout... Might be a big AnonymousInvestor 01/24/18 03:57:25 AM
#14171   Nice bump today. Guess she'll start going back radly 01/23/18 04:59:31 PM
#14170   looking real good here Tdash 01/23/18 02:46:22 PM
#14169   And if you're wondering why flu vaccines are MasterK9 01/23/18 01:20:26 PM
#14168   In the interest of necessity and to save Ubertino 01/23/18 10:10:22 AM
#14167   Sold too early, dude. 7Bullet7 01/23/18 09:48:50 AM
#14166   Interesting. A steal below 5 slopak 01/22/18 05:29:10 PM
#14165   This broad spectrum flu vaccine must conservatively be Ubertino 01/22/18 05:14:55 PM
#14164   Sold INO @ $4.63 at the EOD, took chmcnfunds 01/22/18 04:25:55 PM
#14163   That's what I figure, but "H1N1" was confusing Ubertino 01/22/18 12:31:43 PM
#14162   It will be a universal vaccine for ALL 7Bullet7 01/22/18 12:18:52 PM
#14161   Question - does this cover all HxNx variations Ubertino 01/22/18 08:42:34 AM
#14160   NEWS -- Inovio Pharmaceuticals' Published Universal Flu Vaccine Paulness 01/22/18 08:32:25 AM
#14159   INO may get a little BOOST today NotRichYet2 01/22/18 08:28:02 AM
#14158   Using the current price as a reference, it avav1001 01/18/18 07:24:14 PM
#14157   Not unless you can travel to the past. kpisme 01/18/18 01:55:00 PM
#14156   The Wistar Institute Awarded More Than $1.4 Million chmcnfunds 01/18/18 01:51:13 PM
#14155   Agreed! I’ve loaded all I can afford down Imaginaryharry 01/18/18 12:18:03 AM
#14154   Time to load here. Easy double! $$$$ harry crumb 01/14/18 08:42:19 PM
#14153   Tax selling drove this down at the end MasterK9 01/12/18 09:41:15 AM
#14152   1/12/2018 HC Wainwright Set Price Target Buy $13.00 chmcnfunds 01/12/18 08:17:06 AM
#14151   That? arvitar 01/09/18 01:11:49 PM
#14150   This? Ubertino 01/09/18 12:56:03 PM
#14149   Really? Doesn't look like that to me. arvitar 01/09/18 10:40:14 AM
#14148   Rubber biscuit! kpisme 01/09/18 10:28:53 AM
PostSubject